Funding

PART B: VALORISATION PLAN

SECTION I: ESTIMATION OF COSTS

 

1 Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
€ 100 000

 

 

…in terms of product development
development (prototype D, E)  mechanical and electronic parts, testing                   € 0.7 million

 

The present state was achievd with an investment by the owners. The amount of € 700 000 is a loan by the owners int he next calculations.

…in terms of mass production
production preparation: obtaining all necessary permissions  supplier network         € 0.35 million

technology investment / composite production line / surface treatment                     € 2.5 million

purchase & furnishing of building/ assembly plant                                                          € 1.95 million

 

… in terms of marketing
300.000 Euro/ year

 

 

 

2 Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs
  Year 1 Year 2 Year 3 Year 4 Year 5
Fixed costs 3 200 000 2 500 000 1 000 000 1 000 000 1 000 000
Personnel 500000 2000000 3000000 3500000 3500000
Other running costs 18000 9000000 18000000 25200000 27000000
Marketing costs 300000 300000 300000 300000 300000
TOTAL EXPECTED COSTS 4 018 000 13 800 000 22 300 000 30 000 000 31 800 000
Price per Unit 2300 2300 2300 2300 2300
Type of Unit  
Number of Units 10 5000 10000 14000 15000
TOTAL Expected Revenues 23000 11500000 23 000000 33200000 34500000
CASH FLOW REQUIRED (REVENUES-COSTS) -3 995 000 -2 300 000 700 000 3 200 000 2 700 000
TOTAL CAPITAL required for five years € 6 300 000

 

 

SECTION 2: QUALITATIVE FACTORS

 

3 Dimension of identified target groups
Several  million people

 

 

4 Evaluation of financial Risks for R&D result
The financial risk highly depends on the availability of the market. Further market survey is very important before investment.

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

1. European Funding

Define relevance of the product with the following potential funding sources and comment

1.

2.

3.

4.

 

2. National Funding
  1. 1. GOP or direct governmental subsidy of € 1,3 million

2.

3.

 

3. Private funding
1. Ventrure Capital …in the magnitude of € 5 million

2.

 

4. Other

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
Very promising project in a matured state of art. The team and small company is able to control the transition from the R&D phase to a market oriented professional production phase. There is a clear view and good strategy for achieving the required market position.

I highly recommend this project for further support and for investing by VC companies.

 

 

 

 

 

 

Decision of evaluation (Please keep only the appropriate)

  • The R&D has a high potential of exploitation
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project